Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Poiret

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Cancer Immunology, Immunotherapy : CII|July 3, 2026
EGFRxCD16 bispecific antibodies orchestrate superior NK cell-mediated lysis of ovarian cancer and NSCLC cell lines in combination with oncolytic virusesSarah Gahbauer, Thomas Poiret
Cytotherapy|October 10, 2025
Long-term cryopreservation of hematopoietic stem and progenitor cells: functional viability beyond two decadesRebecca Axelsson-Robertson, Thomas Poiret, Lyda M Osorio, et al.
Journal of Translational Medicine|March 13, 2024
CAR T cells and T cells phenotype and function are impacted by glucocorticoid exposure with different magnitudeThomas Poiret, Sara Vikberg, Esther Schoutrop, et al.
Frontiers in Immunology|February 24, 2023
Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapseXiao-Hua Luo, Thomas Poiret, Zhenjiang Liu, et al.
Frontiers in Immunology|May 19, 2023
Corrigendum: Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: impact of CMV infection and leukemia relapseXiao-Hua Luo, Thomas Poiret, Zhenjiang Liu, et al.
Frontiers in Immunology|January 10, 2018
Mucosal-Associated Invariant T Cells Display a Poor Reconstitution and Altered Phenotype after Allogeneic Hematopoietic Stem Cell TransplantationMartin Solders, Tom Erkers, Laia Gorchs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in TuberculosisMartin Rao, Davide Valentini, Thomas Poiret, et al.
Journal of Translational Medicine|March 8, 2024
Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacyNeshat Saffarzadeh, Emelie Foord, Eoghan O'Leary, et al.
Clinical & Translational Immunology|March 10, 2025
γδ T cell characterisation in the long term after haematopoietic stem cell transplantation and its impact on CMV control and cGVHD severityFaisal Alagrafi, Arwen Stikvoort, Ahmed Gaballa, et al.
Frontiers in Immunology|October 24, 2025
Production of functional CD19 CAR T cells under hypoxic manufacturing conditionsIsabella Micallef Nilsson, Thomas Poiret, Jinhye Ryu, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|July 3, 2026
EGFRxCD16 bispecific antibodies orchestrate superior NK cell-mediated lysis of ovarian cancer and NSCLC cell lines in combination with oncolytic virusesSarah Gahbauer, Thomas Poiret
Cytotherapy|October 10, 2025
Long-term cryopreservation of hematopoietic stem and progenitor cells: functional viability beyond two decadesRebecca Axelsson-Robertson, Thomas Poiret, Lyda M Osorio, et al.
Journal of Translational Medicine|March 13, 2024
CAR T cells and T cells phenotype and function are impacted by glucocorticoid exposure with different magnitudeThomas Poiret, Sara Vikberg, Esther Schoutrop, et al.
Frontiers in Immunology|February 24, 2023
Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapseXiao-Hua Luo, Thomas Poiret, Zhenjiang Liu, et al.
Frontiers in Immunology|May 19, 2023
Corrigendum: Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: impact of CMV infection and leukemia relapseXiao-Hua Luo, Thomas Poiret, Zhenjiang Liu, et al.
Frontiers in Immunology|January 10, 2018
Mucosal-Associated Invariant T Cells Display a Poor Reconstitution and Altered Phenotype after Allogeneic Hematopoietic Stem Cell TransplantationMartin Solders, Tom Erkers, Laia Gorchs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in TuberculosisMartin Rao, Davide Valentini, Thomas Poiret, et al.
Journal of Translational Medicine|March 8, 2024
Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacyNeshat Saffarzadeh, Emelie Foord, Eoghan O'Leary, et al.
Clinical & Translational Immunology|March 10, 2025
γδ T cell characterisation in the long term after haematopoietic stem cell transplantation and its impact on CMV control and cGVHD severityFaisal Alagrafi, Arwen Stikvoort, Ahmed Gaballa, et al.
Frontiers in Immunology|October 24, 2025
Production of functional CD19 CAR T cells under hypoxic manufacturing conditionsIsabella Micallef Nilsson, Thomas Poiret, Jinhye Ryu, et al.
Pageof 3